Patent · US Active

Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies

US9457038B2 · kind B2 · utility

10Cited by

7References

11Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Alexandre KAOUKHOV · Newport Beach, US
Christophe Villard · Le Tignet, FR
Philippe BOUISSOU · Valbonne, FR

Key dates

Filing date	May 22, 2014
Grant date	Oct 4, 2016
Priority date	—
Expiry date	Jun 13, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P33/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.